[Exclusive] ROKIT Healthcare's U.S. Subsidiary Pursues Nasdaq Listing...Securities Registration Filed with SEC

ROKIT AMERICA, a Specialist in AI and 3D Bioprinting
Expanding Regenerative Medical Platform Network in North America

ROKIT AMERICA INC, the U.S. subsidiary of leading domestic regenerative medicine company ROKIT Healthcare, is pursuing a listing on the NASDAQ market in the United States.

According to the investment banking (IB) industry on April 16, ROKIT AMERICA recently submitted a securities registration statement (S-1) to the U.S. Securities and Exchange Commission (SEC) to begin the official listing process.

The ticker symbol after the listing has been set as 'RKAM'. Maxim Group LLC is serving as the underwriter for this offering, supporting the overall listing process.

ROKIT AMERICA specializes in an "ultra-personalized regenerative medicine platform," combining artificial intelligence (AI) and 3D bioprinting. The company possesses technology to treat diabetic foot ulcers and other conditions by utilizing patients' own tissues, and is also making significant strides in the anti-aging health supplement sector.

The company’s financial performance is also solid. According to disclosed documents, ROKIT AMERICA recorded revenue of USD 7.43 million (approximately KRW 1.06 billion) last year, a growth of about 140% compared to the previous year, and achieved net income of USD 1.58 million (approximately KRW 230 million), thereby establishing a profitable structure. This demonstrates the company's competitiveness not only in technology but also in profitability, meeting the stringent standards of the NASDAQ market.

ROKIT AMERICA plans to focus the funds secured through the listing on expanding its regenerative medicine platform sales network in the North American market and on research and development (R&D) for next-generation pipelines such as cartilage and kidney regeneration.

A ROKIT Healthcare official stated, "We cannot yet disclose the exact size of the public offering related to the NASDAQ listing."

This content was produced with the assistance of AI translation services.